14
Participants
Start Date
November 30, 2015
Primary Completion Date
June 10, 2019
Study Completion Date
June 15, 2019
Metformin
background drug
saxagliptin
background drug
AZD9668
study drug
placebo
placebo for AZD9668 to be added to background drugs
Allegheny Health Network, Pittsburgh
Collaborators (1)
National Institutes of Health (NIH)
NIH
University of Pittsburgh
OTHER
University of South Florida
OTHER
AstraZeneca
INDUSTRY
Nick Giannoukakis, PhD
OTHER